Mankind Pharma Brand Guidelines: The Juneja Brothers, Manforce, a 2023 IPO & Bharat Serums

A 1991 company that started selling in 1995.

Mankind Pharma was incorporated in 1991 and began operating in 1995, according to the company’s own timeline and English Wikipedia. It was founded by two brothers, Ramesh C. Juneja and Rajeev Juneja, and is headquartered in the Okhla district of New Delhi. The company’s website today names Ramesh Juneja as chairman and Rajeev Juneja as vice-chairman and managing director.

English Wikipedia, citing Indian business press, says the company started with about 20 employees and sold in two states in its first year. Its first strategy was price: it targeted price-sensitive drugs and rural markets, and its early products — the antibacterial Zenflox and the antibiotic Moxikind CV — were priced well below established rivals, according to a 2009 Business Standard account cited there.

From that base the company widened its range. It entered chronic therapies, set up its first research centre at IMT Manesar in Haryana and incorporated subsidiaries in the United States and Singapore, its timeline says, and later launched specialty divisions for cardiovascular, respiratory, central nervous system and diabetes care.

Manforce, Prega News and a run of acquisitions.

What made Mankind visible to the public was consumer healthcare. The company moved into over-the-counter products in 2007, focusing first on sexual health, English Wikipedia says, and its timeline credits the launch of Manforce condoms and the Prega News home pregnancy test with taking it into consumer brands.

The company also added brands by buying them. In 2022, English Wikipedia says, citing Business Today, it bought Panacea Biotec Pharma’s domestic formulation brands in India and Nepal; the company says those brands took it into transplant and oncology. It also bought the Daffy and Combihale brands from Dr. Reddy’s Laboratories, took a majority stake in the Ayurvedic maker Upakarma Ayurveda, and launched the PetStar pet-care brand and an agritech arm, Wikipedia says. Its timeline also lists in-licensing agreements: AstraZeneca’s Symbicort inhaler, Novartis’s inclisiran and Takeda’s vonoprazan.

On its own account, Mankind was the first Indian company to launch the hormone dydrogesterone, and it describes a facility at Udaipur as India’s first fully integrated plant for the drug. English Wikipedia, citing The Economic Times, dates the launch, under the brand Dydroboon, to 2019. In 2017 it set up Pathkind Labs, a diagnostics business, Wikipedia says.

Most of its products are made in India. The company says it runs 32 facilities across eight locations, with clusters at Paonta Sahib in Himachal Pradesh and plants in Uttarakhand, Sikkim, Maharashtra, Rajasthan and Andhra Pradesh, as well as sites in Nepal and Germany. It says one Paonta Sahib unit, which makes eye and ear drops among other products, holds US FDA approval; its timeline also records the first inspection of its Paonta Sahib facility by the US regulator.

The same pages show how much of the supply chain the group keeps in-house. At Paonta Sahib, the company says, Unit I makes injectables in ampoules and vials and Unit II makes tablets, capsules, syrups and sachets, while two subsidiaries there make droppers for liquid medicines and sorbitol, an ingredient used in formulations. Its agritech arm makes crop-protection formulations at Paonta Sahib and at Vadodara in Gujarat.

Design and documentation.

India’s drug makers are spread across several states, and some regions have become clusters. English Wikipedia’s article on the pharmaceutical industry in Gujarat calls Ahmedabad and Vadodara the state’s pharmaceutical hubs and records that the state government declared Gujarat a “pharma hub” in 2000; Torrent Pharma’s plants at Chhatral and Dahej are in the same state. Glenmark’s August 2026 factsheet lists formulation plants in Goa, Sikkim, Madhya Pradesh, Himachal Pradesh and Maharashtra, as well as in Argentina, the United States and the Czech Republic.

Many of the companies in this guide began as family firms and still carry their founders’ stories. Glenmark’s name, English Wikipedia says, was made from the names of its founder’s two sons; Torrent Pharma started in 1959 as Trinity Laboratories and belongs to a group that also runs power and gas businesses. Where a company’s history rests only on its own website, this guide says so.

The industry has its own meeting places. CPHI India, the Informa trade fair that bills itself as “the heart of South Asia’s pharma,” runs from 23 to 26 November 2026 at the IICC in Delhi, alongside the PMEC India machinery show at Greater Noida, according to its website. DCAT Week, which calls itself “the premier event for the global bio/pharmaceutical business ecosystem,” is next held in New York City from 15 to 18 March 2027.

This guide looks at how each company presents itself — in plant photographs, laboratory imagery, packs, founder portraits and corporate colours — and sets out what can be checked about each one: who founded it, who owns it and where it says its medicines are made, marking clearly what rests only on the company’s own word.

A 2023 listing and a biologics purchase.

Mankind stayed private for almost three decades. Its initial public offering came in April 2023 and was entirely an offer for sale of existing shares by promoters and other shareholders, Medical Dialogues reported; the shares made their debut on the BSE and the National Stock Exchange of India on 9 May 2023. The founding family remains in charge of the board.

The biggest step since then was a purchase. In July 2024 Mankind announced that it would buy all of Bharat Serums and Vaccines (BSV), the biopharmaceutical company in which the private equity firm Advent International had taken a majority stake in 2017, according to BSV’s own history. On 23 October 2024 Mankind said it had completed the deal, Medical Dialogues reported the next day. BSV, which dates its start to 1971, brought a portfolio in women’s health, fertility, critical care and immunoglobulins, and more than 2,500 staff; vice-chairman Rajeev Juneja welcomed them to “the Mankind family.”

BSV gave the group biologics and plants of a different kind. The BSV website, now presented as part of Mankind, describes a plant at Ambernath near Mumbai and a facility in Germany, and a subsidiary in the Philippines. Under Advent, BSV says, it bought TTK Healthcare’s human pharma business and the Malaysian companies Firstline Pharmaceuticals and Genomicks, adding to its work in IVF, and its Ambernath plant received EU GMP and Brazilian ANVISA approvals.

The corporate name has stayed the same throughout: a plain English word that now sits above prescription brands, consumer brands such as Manforce and Prega News, diagnostics, pet care and, since 2024, BSV with its own name and history.

For a design guide, Mankind Pharma shows how one company name can carry consumer brands, prescription generics and an acquired biologics business without changing. Compare Cipla, the drug maker founded in Bombay in 1935, and Alkem, a family-founded generics group that listed in 2015. For this guide we use a deep teal, a pale mist and a warm saffron with a serif, an unofficial interpretation; no product or logo is reproduced.

Keep Mankind Pharma’s identity on hand — save it to a board in the Made Good inspiration library.